The recall covers more than 7,000 bottles of duloxtine, sold as Cymbalta, due to the presence of nitrosamines.

“There’s a very narrow range of doses where ketamine is effective for depression but not anesthetic,” Krystal says. For treating other conditions – such as anxiety, pain, PTSD, or bipolar ...

Mindfulness-based stress reduction (MBSR) was found to be as effective as the antidepressant escitalopram in reducing agoraphobia, panic disorder, generalized anxiety disorder, and social anxiety ...

Liver X receptor beta (LXRβ) shows potential in reducing depression and anxiety by improving neurogenesis, reducing ...

A popular and ancient herbal remedy, aiding in conditions such as allergies, arthritis, digestive disorders, respiratory ...

Depression, defined by (World Health Organization ... Additionally, they exhibit antioxidant properties and anti-inflammatory solid effects, which are believed to contribute to their potential ...

Placebos Reduce Stress, Anxiety, Depression -- Even When People Know They Are Placebos Aug. 23, 2024 — A study found that nondeceptive placebos, or placebos given with people fully knowing they ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Mindfulness meditation appeared to be similar to ...

[27] Most of these antidotes either have serotonin-blocking properties (especially 5HT-2 ... Typical side effects associated with yohimbine include anxiety, nausea, flushing, urinary urgency ...

According to the FDA, Duloxetine -- which is marketed as Cymbalta -- is used to treat depression, anxiety, and other mood disorders. The drug is classed as a “selective serotonin/norepinephrine ...

As Wes Streeting suggests new weight-loss jabs could be given to unemployed people to help them get back into work, doctors ...